Novus Therapeutics (NVUS) Stock Rating Upgraded by ValuEngine - Fairfield Current

Novus Therapeutics (NVUS) Stock Rating Upgraded by ValuEngine  Fairfield Current

Novus Therapeutics (NASDAQ:NVUS) was upgraded by ValuEngine from a “hold” rating to a “buy” rating in a research report issued on Monday. Separately ...



Comments

Popular posts from this blog

Uveitis Eye Inflammation Causes, Symptoms & Treatment

Robert Zakar gives back to community

Goopy Eyes: Causes and Treatment